title: Ultraviolet recall-like phenomenon occurring after piperacillin, tobramycin, and ciprofloxacin therapy.
authors.affiliation: Department of Dermatology, Baylor College of Medicine, Houston, TX, USA.
authors.forename: R S
authors.initials: RS
authors.lastname: Krishnan
authors.forename: A T
authors.initials: AT
authors.lastname: Lewis
authors.forename: J S
authors.initials: JS
authors.lastname: Kass
authors.forename: S
authors.initials: S
authors.lastname: Hsu
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000009:adverse effects* / Q000627:therapeutic use; D003875:Drug Eruptions / Q000188:drug therapy / Q000473:pathology*; D004890:Erythema / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use; D010406:Penicillins / Q000009:adverse effects* / Q000627:therapeutic use; D010878:Piperacillin / Q000009:adverse effects* / Q000627:therapeutic use; D014031:Tobramycin / Q000009:adverse effects* / Q000627:therapeutic use; D014466:Ultraviolet Rays
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D010406:Penicillins; D002939:Ciprofloxacin; D014031:Tobramycin; D010878:Piperacillin; D008775:Methylprednisolone